Keeping tabs on Covid-19: Starpharma creates slow release remdesivir nanoparticl…
The Pharma Data
SEPTEMBER 11, 2020
“The ability to deliver remdesivir via a long-acting, subcutaneous injection has the potential to expand its application in countries with less developed healthcare systems and help improve patient convenience,” Fairley added. Covid-19 command center aims to accelerate clinical research by individual sponsors to combat disease.
52 
Let's personalize your content